by Co-Diagnostics | Mar 22, 2018 | News Release
Project moving forward on schedule, with production to begin in Q3 2018 SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX), a diagnostics company with a unique, proprietary platform for the development of molecular diagnostics,...
